During the past decade, Ospedale San Paolo conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 12 clinical trials were completed, i.e. on average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 8 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Paolo" #1 sponsor was "University of Milan" with 17 trials, followed by "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 6 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Paolo" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 5 trials as a collaborator, "ASST Santi Paolo e Carlo" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Centro Hospitalar Lisboa Ocidental" with 2 trials as a collaborator and "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Paolo" are "Lung Cancer" (5 trials), "COVID-19" (4 trials), "Critical Illness" (4 trials), "ARDS, Human" (3 trials) and "Acute Respiratory Distress Syndrome" (3 trials). Many other conditions were trialed in "Ospedale San Paolo" in a lesser frequency.

Most popular intervention types in "Ospedale San Paolo" are "Drug" (61 trials), "Other" (16 trials), "Device" (15 trials), "Procedure" (10 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "cisplatin" (4 trials), "fluorouracil" (4 trials), "Docetaxel" (3 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Paolo" are 105 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 20 active trials in "Ospedale San Paolo". 1 are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in Ospedale San Paolo, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Paolo, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 21 trials that are defined as “Not Applicable".

Ospedale San Paolo has several departments that took part in Clinical trials: "Ospedale San Carlo Borromeo - Cardiologia UCC" - 6 trials, "Osp. San Carlo Borromeo Divisione di Oncologia Medica" - 5 trials, "Asst Santi Paolo E Carlo; Unita Operativa Di Oncologia Medica" - 3 trials, "Dental Clinic San Paolo Hospital" - 2 trials, "Ospedale San Paolo, Divisione Di Cardiologia" - 2 trials